Urban Wealth Management’s GSK GSK Stock Holding History

Urban Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1K	Buy	+21	New	+$1.16K	﹤0.01%	318

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Urban Wealth Management's GSK Position: Q2 2022 in Review

Urban Wealth Management opened a new position in GSK (GSK) in Q2 2022: 21 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #318 among its holdings.

900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

Urban Wealth Management held 21 shares of GSK worth $1K as of Q2 2022.
GSK was a new Urban Wealth Management position in Q2 2022.
GSK made up ﹤0.01% of Urban Wealth Management's portfolio in Q2 2022, its #318 holding.
900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Urban Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.